课题基金 / 基金详情

Small molecule inhibitor of IL-1b signaling in degenerative disc disease

Small molecule inhibitor of IL-1b signaling in degenerative disc disease
退行性椎间盘疾病中 IL-1b 信号传导的小分子抑制剂
批准号：
468983
负责人：
Mwale Fackson
金额：
$53.5万
依托单位：
Lady Davis Institute for Medical Research (Mtl)
依托单位国家：
加拿大
项目类别：
Operating Grants
财政年份：
2022
资助国家：
加拿大
项目状态：
未结题
起止时间：
2022-09-01 至 2027-09-01
来源：
https://webapps.cihr-irsc.gc.ca/decisions/p/project_details.html?applId=468983&lang=en
关键词：
Disc Degeneration Disease-Modifying Drug Link N Low Back Pain Tissue Engineering

项目摘要

项目成果

Mwale Fackson的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
Intervertebral disc degeneration is a progressive disorder that affects about 60% of the population by age 70, often resulting in debilitating low back pain. As disc repair does not occur spontaneously, surgical intervention is often needed for treating p
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
The efficacy of Link N as a mediator of repair in Intervertebral Disc Degeneration
海外基金